Abiopharma

Director Glastra Matthijs 🔴 sold 323 shares of NOVANTA INC (NOVT) at $130.14 Transaction Date: Jan 08, 2026 | Filing ID: 000023

Director Hudson Frederick M. 🟡 adjusted position in 0 shares (1 derivative) of SUPERNUS PHARMACEUTICALS, INC. (SUPN) at $12.98 Transaction Date: Jan 09, 2026 | Filing ID: 001817

(99% Neutral) Avadel Pharmaceuticals (AVDL) Announces Business Combination

Illumina, Inc. - Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026

📋 MARK R MUNCH (Officer) plans to sell 7K shares of Bruker Corporation (at $55.00 each, total $385K) Filed: Jan 12, 2026 | ID: 000324

Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026

New Form SCHEDULE 13G - Galecto, Inc. Filed: 2026-01-12 AccNo: 0001193125-26-010366 Size: 8 KB

📋 Rogers Erica J. (Ex-Director) plans to sell 10K shares of Sight Sciences, Inc. (at $7.38 each, total $74K) Filed: Jan 12, 2026 | ID: 000260

(90% Positive) BridgeBio Pharma (BBIO) Provides Update on increase for chroni

New Form S-8 - Anixa Biosciences Inc Filed: 2026-01-12 AccNo: 0001493152-26-001847 Size: 630 KB

(80% Positive) Astrana Health Inc (ASTH) Reports Q1 2026 Financial Results

New Form 8-K/A - JOINT Corp Filed: 2026-01-12 AccNo: 0001612630-26-000008 Size: 144 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

(99% Neutral) Cyclacel Pharmaceuticals Inc. (CYCCP) Provides Business Update

New Form 3 - Indaptus Therapeutics, Inc. Filed: 2026-01-12 AccNo: 0001493152-26-001846 Size: 3 KB

(70% Positive) Oncolytics Biotech Inc (ONCY) Provides Update on innovations for pelareorep